LISATA THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets
LISATA THERAPEUTICS, INC. (LSTA) reported Gain (Loss) on Disposition of Assets of -$3.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-02-29
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2019-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2018-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2018-09-30 was $50.00K.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2023 was -$3.00K.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2022 was $0.00.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- LISATA THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2018 was $1.43M.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 9 month as first filed | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | -$3.00K 10-K · filed 2024-02-29 | |||||
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $0.00 derived: sum of 2 quarters · filed 2020-03-05 | $0.00 10-K · filed 2020-03-05 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $50.00K derived: sum of 2 quarters · filed 2020-03-05 | $1.43M 10-K · filed 2020-03-05 | |||
| 2018-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.43M 10-Q · filed 2019-11-06 | $1.43M 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | $1.38M 10-Q · filed 2019-08-08 | |||||
| 2017-12-31 | -$36.21K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$212.00K 10-K · filed 2019-03-14 | -$211.81K 10-K · filed 2018-03-22 | |||
| 2017-09-30 | -$175.79K 10-Q · filed 2018-11-08 | |||||
| 2016-12-31 | -$591.31K 10-K · filed 2018-03-22 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |